A hollow mesoporous manganese oxide based multifunctional nanozyme with self-propelled nanomotor behavior and direct copper binding ability for synergistic therapy of glioblastoma with hypoxia alleviation

Template-free Synthesis of Mesoporous and Crystalline Transition Metal Oxide Nanoplates with Abundant Surface Defects

The design of hollow mesoporous nanostructures for cascade catalytic reactions can inject new vitality into the development of nanostructures. In this study, we report a versatile cooperative template-directed coating method for the synthesis of hollow and yolk-shell mesoporous zirconium titanium oxide nanospheres with varying compositions (ZrO2 content from 0 to 100%), high surface areas (465 m2·g−1) and uniform mesopores. In particular, the hexadecylamine (HDA) used in the coating procedure serves as a soft template for silica@mesostructured metal oxide core-shell nanosphere formation. By a facile solvothermal treatment route with an ammonia solution and calcination in air, the silica@mesostructured zirconium titanium oxide spheres can be converted into highly uniform hollow zirconium titanium oxide spheres. By simply replacing hard template silica nanospheres with core-shell silica nanocomposites, the synthesis approach can be further used to prepare yolk-shell mesoporous structures through the coating and etching process. The approach is similar to the preparation of mesoporous silica nanocomposites from the self-assembly of the core, the soft template cetyltrimethylammonium bromide (CTAB) and a silica precursor and can be extended as a general method to coat mesoporous zirconium titanium oxide on other commonly used hard templates (e.g., mesoporous silica spheres, mesoporous organosilica ellipsoids, polymer spheres, and carbon nanospheres). The presence of highly permeable mesoporous channels in the zirconium titanium oxide shells has been demonstrated by the reduction of 4-nitrophenol with yolk-shell Au@mesoporous zirconium titanium oxide as the catalyst. Moreover, a cascade catalytic reaction including an acid catalyzed step and a catalytic hydrogenation to afford benzimidazole derivatives can be carried out very effectively by using the accessible acidity of the yolk-shell structured mesoporous zirconium titanium oxide spheres containing a Pd core as a bifunctional catalyst, which makes the hollow zirconium titanium oxide spheres a practicable candidate for advanced catalytic systems.

Synthesis of MoS2 nanoparticle deposited graphene/mesoporous MnOx nanocomposite for high performance super capacitor application

Sonodynamic therapy (SDT) typically suffers from compromised anticancer efficacy owing to the low reactive oxygen species (ROS) yield and complicated tumor microenvironment (TME) which can consume ROS and support the occurrence and development of tumors. Herein, ultrathin‐FeOOH‐coated MnO2 nanospheres (denoted as MO@FHO) as sonosensitizers which can not only facilitate ultrasound (US)‐triggered ROS but also tune the TME by hypoxia alleviation, H2O2 consumption as well as glutathione (GSH) depletion are designed. The FeOOH coating will boost the production yield of singlet oxygen (1O2) and hydroxyl radicals (•OH) by inhibiting the recombination of US‐initiated electron–hole pairs and Fenton‐like reaction, respectively. Additionally, the catalase‐like and GSH peroxidase‐like activities of MO@FHO nanospheres enable them to break the TME equilibrium via hypoxia alleviation and GSH depletion. The combination of high ROS yield and fundamental destruction of TME equilibrium results in satisfactory antitumor outcomes, as demonstrated by the high tumor suppression efficacy of MO@FHO on MDA‐MB‐231‐tumor‐bearing mice. No obvious toxicity is detected to normal tissues at therapeutic doses in vivo. The capability to modulate the ROS production and TME simultaneously can afford new probability for the development of advanced sonosensitizers for synergistic comprehensive cancer therapy.

Mesoporous manganese oxides for NO2 assisted catalytic soot oxidation

Synthesis and characterization of metal chalcogenide modified graphene oxide sandwiched manganese oxide nanofibers on nickel foam electrodes for high performance supercapacitor applications

Virus-inspired nanocages potentiate glioblastoma sonochemotherapy via structure-function mimicry.

Sonodynamic therapy (SDT) is a noninvasive technique for local antitumor treatment; however, its clinical application is often limited by the low tumor accumulation of SDT agents, tumor's hypoxic microenvironment, and cytoprotective effects of autophagy. To address these issues, herein we developed surface-engineered chlorella (Chl, a green algae) as a targeted drug carrier and sustainable oxygen supplier (via photosynthesis) for significantly improved SDT via hypoxia alleviation as well as autophagy inhibition of chloroquine phosphate. In this design, the macrophage membrane was coated onto Chl to form macrophage-mimetic Chl (MChl) to increase its biocompatibility and targeted tumor accumulation driven by the inflammatory-homing effects of macrophage membranes. In addition, the membrane coating on Chl allowed lipid insertion to yield β-cyclodextrin (β-CD) modified MChl (CD-MChl). Subsequently, supramolecular conjugates of MChl-NP were constructed via host-guest interactions between CD-MChl and adamantane (ADA)-modified liposome (ADA-NP), and the anchored liposome went with CD-MChl hand-in-hand to the tumor tissues for co-delivery of Chl, hematoporphyrin, and chloroquine phosphate (loaded in ADA-NP). The synergistic therapy achieved via local oxygenation, SDT, and autophagy inhibition maximally improved the therapeutic efficacy of MChl-CQ-HP-NP against melanoma. Tumor rechallenging results revealed that the changes of tumor microenvironment including hypoxia alleviation, SDT induced immunogenic cell death, and autophagy inhibition collectively induced a strong antitumor immune response and memory.

Silver nanoparticle/r-graphene oxide deposited mesoporous-manganese oxide nanocomposite for pollutant removal and supercapacitor applications

Effective removal of methylene blue using nanoscale manganese oxide rods and spheres derived from different precursors of manganese

Noble metal nanocrystals with different shapes and compositions are embedded in hollow mesoporous metal oxide microspheres through an ultrasonic aerosol spray. Polystyrene (PS) nanospheres are employed simultaneously as a hard template to create hollow interiors inside the oxide microspheres and as the carrier to bring pregrown metal nanocrystals, including Pd nanocubes, Au nanorods, and Au core/Pd shell nanorods, into the oxide microspheres. Calcination removes the PS template and causes the metal nanocrystals to adsorb on the inner surface of the hollow oxide microspheres. The catalytic performances of the Pd nanocube‐embedded TiO2 and ZrO2 microspheres are investigated using the reduction of 4‐nitrophenol as a model reaction. The presence of the mesopores in the oxide microspheres allows the reactant molecules to diffuse into the hollow interiors and subsequently interact with the Pd nanocubes. The embedding of the metal nanocrystals in the hollow oxide microspheres prevents the aggregation of the metal nanocrystals and reduces the loss of the catalyst during recycling. The Pd nanocube‐embedded ZrO2 microspheres are found to exhibit a much higher catalytic activity, a much larger catalytic reaction rate, and a superior recyclability in comparison with a commercial Pd/C catalyst. This preparation approach could potentially be utilized to incorporate various types of mono‐ and multimetallic nanocrystals with different sizes, shapes, and compositions into hollow mesoporous oxide microspheres. Such a capability can facilitate the studies of the catalytic properties of various combinations of metal nanocrystals and metal oxide supports and therefore guide the design and creation of high‐performance catalysts.

Aerobic self‐esterification of primary alcohols catalyzed by mesoporous metal oxides (manganese and cobalt oxides) is reported under base and solvent free conditions. For a range of aliphatic alcohols, up to 90 % conversions to esters was achieved. The catalytic reaction is likewise applicable to neat aldehydes as substrates with yields of up to 86 %. High pressure batch reaction for ethanol to ethyl acetate led to 22 % yield. Isotope labeling studies indicated decarboxylation on the catalyst surface. Mechanistic and kinetic experiments implicate oxygen rebound and α‐carbon removal as intermediate steps. Mesoporous cobalt oxide showed about 20 % higher catalytic activity compared to mesoporous manganese oxide.

We use low-molecular-weight branched polyethylenimine (PEI) to produce cytocompatible reduced graphene oxide quantum dots (rGOQD) as a photothermal agent and covalently bind it with the photosensitizer IR-820. The rGOQD/IR820 shows high photothermal conversion efficiency and produces reactive oxygen species (ROS) after irradiation with near-infrared (NIR) light for photothermal/photodynamic therapy (PTT/PDT). To improve suspension stability, rGOQD/IR820 was PEGylated by anchoring with the DSPE hydrophobic tails in DSPE-PEG-Mal, leaving the maleimide (Mal) end group for covalent binding with manganese dioxide/bovine serum albumin (MnO2/BSA) and targeting ligand cell-penetrating peptide (CPP) to synthesize rGOQD/IR820/MnO2/CPP. As MnO2 can react with intracellular hydrogen peroxide to produce oxygen for alleviating the hypoxia condition in the acidic tumor microenvironment, the efficacy of PDT could be enhanced by generating more cytotoxic ROS with NIR light. Furthermore, quercetin (Q) was loaded to rGOQD through π-π interaction, which can be released in the endosomes and act as an inhibitor of heat shock protein 70 (HSP70). This sensitizes tumor cells to thermal stress and increases the efficacy of mild-temperature PTT with NIR irradiation. By simultaneously incorporating the HSP70 inhibitor (Q) and the in situ hypoxia alleviating agent (MnO2), the rGOQD/IR820/MnO2/Q/CPP can overcome the limitation of PTT/PDT and enhance the efficacy of targeted phototherapy in vitro. From in vivo study with an orthotopic brain tumor model, rGOQD/IR820/MnO2/Q/CPP administered through tail vein injection can cross the blood-brain barrier and accumulate in the intracranial tumor, after which NIR laser light irradiation can shrink the tumor and prolong the survival times of animals by simultaneously enhancing the efficacy of PTT/PDT to treat glioblastoma.

Nickel-doped mesoporous manganese oxides for enhanced peroxymonosulfate-based oxidation of tetracycline hydrochloride: Performance and mechanism

pH-responsive Fe/Mn-doped mesoporous silica nanozymes for synergistic chemophotothermal therapy in breast cancer via hypoxia alleviation and controlled drug release